Novartis AG is 176.2x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($293.70 B vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VRDN | NVS |
|---|---|---|
| Market cap | $1.67 B | $293.70 B |
| US-listed rank | #2250 | #46 |
| Revenue (latest FY) | $70.85M | - |
| Net income (latest FY) | -$342.60M | - |
| Net margin | -483.6% | - |
| SEC filings | 794 | 947 |
Novartis AG is 176.2x more valuable than Viridian Therapeutics, Inc.DE by market capitalization ($293.70 B vs $1.67 B).
Full pages: Viridian Therapeutics, Inc.DE and Novartis AG, or browse the full rankings.